233 related articles for article (PubMed ID: 31693696)
1. Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany.
Christensen S; Wolf E; Altevers J; Diaz-Cuervo H
PLoS One; 2019; 14(11):e0224279. PubMed ID: 31693696
[TBL] [Abstract][Full Text] [Related]
2. Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.
Pourcher V; Gourmelen J; Bureau I; Bouee S
PLoS One; 2020; 15(12):e0243529. PubMed ID: 33332394
[TBL] [Abstract][Full Text] [Related]
3. Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada.
Enns B; Min JE; Panagiotoglou D; Montaner JSG; Nosyk B;
BMC Health Serv Res; 2019 Sep; 19(1):626. PubMed ID: 31481056
[TBL] [Abstract][Full Text] [Related]
4. Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis.
Krüger K; von Hinüber U; Meier F; Tian H; Böhm K; Jugl SM; Borchert K; Meise D; König C; Braun S
Rheumatol Int; 2018 Nov; 38(11):2121-2131. PubMed ID: 30094685
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
6. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
[TBL] [Abstract][Full Text] [Related]
7. Healthcare resource utilization and costs associated with renal, bone and cardiovascular comorbidities among persons living with HIV compared to the general population in Quebec, Canada.
Baribeau V; Kim CJ; Lorgeoux RP; Brisebois J; Tossonian H; Lachaine J
PLoS One; 2022; 17(7):e0262645. PubMed ID: 35816474
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of late presentation in HIV disease in Austria: a comparison of the initial costs imposed by advanced HIV disease vs. non-late presentation.
Grabmeier-Pfistershammer K; Rieger A; Schröck T; Schlag M
Wien Klin Wochenschr; 2013 Jul; 125(13-14):402-7. PubMed ID: 23807043
[TBL] [Abstract][Full Text] [Related]
9. The impact of socioeconomic factors on the healthcare costs of people living with HIV in Turkey.
Özdemir HÖ; Tosun S; Kabadurmuş FNK; Özdemir D
BMC Public Health; 2020 Mar; 20(1):368. PubMed ID: 32197598
[TBL] [Abstract][Full Text] [Related]
10. Greater burden of chronic comorbidities and co-medications among people living with HIV versus people without HIV in Japan: A hospital claims database study.
Ruzicka DJ; Imai K; Takahashi K; Naito T
J Infect Chemother; 2019 Feb; 25(2):89-95. PubMed ID: 30396821
[TBL] [Abstract][Full Text] [Related]
11. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings.
Gore M; Sadosky A; Stacey BR; Tai KS; Leslie D
Spine (Phila Pa 1976); 2012 May; 37(11):E668-77. PubMed ID: 22146287
[TBL] [Abstract][Full Text] [Related]
12. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
Centorrino F; Mark TL; Talamo A; Oh K; Chang J
J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database.
Ruzicka DJ; Imai K; Takahashi K; Naito T
BMJ Open; 2018 Jun; 8(6):e019985. PubMed ID: 29903786
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and related drug cost of comorbidities in HIV-infected patients receiving highly active antiretroviral therapy in Taiwan: A cross-sectional study.
Yang CJ; Wang HY; Chou TC; Chang CJ
J Microbiol Immunol Infect; 2019 Oct; 52(5):720-727. PubMed ID: 31358463
[TBL] [Abstract][Full Text] [Related]
15. Excess costs of non-infectious comorbidities among people living with HIV - estimates from Denmark and Sweden.
Hjalte F; Calara PS; Blaxhult A; Helleberg M; Wallace K; Lindgren P
AIDS Care; 2018 Sep; 30(9):1090-1098. PubMed ID: 29774749
[TBL] [Abstract][Full Text] [Related]
16. Healthcare utilization and direct costs of non-infectious comorbidities in HIV-infected patients in the USA.
Gallant J; Hsue P; Budd D; Meyer N
Curr Med Res Opin; 2018 Jan; 34(1):13-23. PubMed ID: 28933204
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M
BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study.
Lee YY; Tang CH; Chen JH; Kuo LN; Ko Y
Curr Med Res Opin; 2018 Apr; 34(4):735-740. PubMed ID: 29243513
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of the prevalence of psychiatric illness and sleep disturbance as co-morbidities of HIV infection in the UK.
Chaponda M; Aldhouse N; Kroes M; Wild L; Robinson C; Smith A
Int J STD AIDS; 2018 Jun; 29(7):704-713. PubMed ID: 29393007
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and cost of HIV-associated weight loss in a managed care population.
Siddiqui J; Phillips AL; Freedland ES; Sklar AR; Darkow T; Harley CR
Curr Med Res Opin; 2009 May; 25(5):1307-17. PubMed ID: 19364303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
